digitalmediawritings

Pharmacotherapy For Cardiovascular Disorders Discussion

Pharmacotherapy For Cardiovascular Disorders Discussion

Need Help Writing an Essay?

Tell us about your assignment and we will find the best writer for your paper

Write My Essay For Me

heart disease remains the No. 1 killer in America; nearly half of all Americans have high blood pressure, high cholesterol, or smoke—some of the leading risk factors for heart disease…

—Murphy et al., 2018

Despite the high mortality rates associated with cardiovascular disorders, improved treatment options do exist that can help address those risk factors that afflict the majority of the population today.

As an advanced practice nurse, it is your responsibility to recommend appropriate treatment options for patients with cardiovascular disorders. To ensure the safety and effectiveness of drug therapy, advanced practice nurses must consider aspects that might influence pharmacokinetic and pharmacodynamic processes such as medical history, other drugs currently prescribed, and individual patient factors. Pharmacotherapy For Cardiovascular Disorders Discussion

Reference: Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db328.htm

 

ORDER  HERE A PLAGIARISM-FREE PAPER HERE

INSTRUCTIONS:

 

To Prepare

  • Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
  • Review the case study assigned by your Instructor for this Assignment.
  • Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
  • Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
  • Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
  • Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient. Pharmacotherapy For Cardiovascular Disorders Discussion

 

Write a 2 page paper that addresses the following:

  • Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
  • Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
  • Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.

 

 

                                     CASE STUDY

LM is an 89-year-old female resident of a long-term care facility who has been experiencing multiple falls, some resulting in injuries such as bruising and skin tears. Over the last six months, her ambulation status has declined from independent to wheelchair level. She complains of leg pain when walking more than short distances across the nursing unit. Pharmacotherapy For Cardiovascular Disorders Discussion

PMH:

HTN

Alzheimer’s disease

Hypothyroidism

Osteoarthritis

Diabetes

MEDICATIONS:

Amlodipine 10 mg QD

Donepezil 10 mg QHS

Levothyroxine 0.88 mg QAM

Celecoxib 200 mg QD

Furosemide 40 mg QAM

Metformin 500mg, 1 BID

Glyburide 5mg, 1 BID

ALLERGIES: NKA

SOCIAL HISTORY:

Widowed with two adult children living in town, a retired photographer and owner of an art supply store

VITALS:    LABS:
Weight: 129 lbs           TSH 2.45        Free T4 0.98
Height: 64 inches
Na 135, K+ 3.8, Cl 99, CO2 25,

BP: Supine = 177/82
Glucose 101, SCr 0.9, BUN 42

HR: 78 bpm
WBC 7.0, RBC 4.5, Hgb 11.9, Hct 34.1

Plt 255
Cr: 1.6 UA: Clear
eGFR: 45 ml/min
PE:

HEENT: Normocephalic, no evidence of trauma, PERRLA, EOMI, Dry mucous membranes

CV: RRR

Respiratory: Clear to auscultation bilaterally

Abdomen: Soft, non-tender, no masses or guarding

G/U: Skin intact, assisted with toileting and personal hygiene by staff

Extremities: Bilateral 2+ edema to lower extremities; skin dry, dark bruising, and skin tear to right elbow and forearm

Neuro: Alert and oriented to person only. MMSE 18/30, stable over the last 12 months.
PAIN ASSESSMENT:

Faces pain scale: No pain occurs at rest; upon walking, pain is moderate to severe.

 

REQUIRED READINGS:

  • Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants(2nd ed.) St. Louis, MO: Elsevier. Pharmacotherapy For Cardiovascular Disorders Discussion
    • Chapter 33, “Review of Hemodynamics” (pp. 285–289)
    • Chapter 37, “Diuretics” (pp. 290–296)
    • Chapter 38, “Drugs Acting on the Renin-Angiotensin-Aldosterone System” (pp. 297–307)
    • Chapter 39, “Calcium Channel Blockers” (pp. 308–312)
    • Chapter 40, “Vasodilators” (pp. 313–317)
    • Chapter 41, “Drugs for Hypertension” (pp. 316–324)
    • Chapter 42, “Drugs for Heart Failure” (pp. 325–336)
    • Chapter 43, “Antidysrhythmic Drugs” (pp. 337–348)
    • Chapter 44, “Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels” (pp. 349–363)
    • Chapter 45, “Drugs for Angina Pectoris” (pp. 364–371)
    • Chapter 46, “Anticoagulant and Antiplatelet Drugs” (pp. 372–388) Pharmacotherapy For Cardiovascular Disorders Discussion

 

 

 

 

 

Let our team of professional writers take care of your essay for you! We provide quality and plagiarism free academic papers written from scratch. Sit back, relax, and leave the writing to us! Meet some of our best research paper writing experts. We obey strict privacy policies to secure every byte of information between you and us.

ORDER ORIGINAL ANSWERS WRITTEN FROM SCRATCH

PLACE YOUR ORDER

SHARE WITH FRIENDS